-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 27, Hengrui Pharmaceuticals issued an announcement stating that its subsidiary Shengdia Biotechnology received the approval of the State Food and Drug Administration to issue the "Drug Supplementary Application Approval Notice" for bevacizumab injection.
Bevacizumab is a humanized anti-VEGF monoclonal antibody, developed by Chugai Pharmaceutical and Roche’s subsidiary Genentech.
After querying the EvaluatePharma database, Avastin's global sales in 2020 are approximately US$5.